GlassScriptPhysician profile
Anna Wagner
NPI 1497307557
$25,868.16
in general payments reported to CMS, 2019-2025
84 companies · $6,448 in 2025
The $6,448 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,123 · 2022: $4,831 · 2023: $5,549 · 2024: $5,917 · 2025: $6,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,726.07 |
| Education | $1,187.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,157.40 | 2021-2025 | Rybrevant, Darzalex, Tecvayli |
| Merck Sharp & Dohme LLC | $1,758.52 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $1,588.80 | 2021-2025 | Enhertu, Calquence, Imfinzi |
| Novartis Pharmaceuticals Corporation | $1,566.58 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,246.22 | 2021-2025 | Opdivo, Opdualag, Reblozyl |
| Seagen INC. | $990.29 | 2021-2025 | Tukysa, Padcev, Adcetris |
| Eisai INC. | $867.05 | 2021-2025 | |
| Daiichi Sankyo INC. | $826.89 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Celgene Corporation | $823.33 | 2021-2025 | Reblozyl, Pomalyst, Opdualag |
| Lilly USA, LLC | $766.19 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Astellas Pharma US INC | $714.99 | 2021-2025 | Vyloy, Xospata, Padcev |
| Pfizer INC. | $680.28 | 2021-2025 | |
| Genzyme Corporation | $667.68 | 2021-2025 | |
| Glaxosmithkline, LLC. | $662.59 | 2021-2025 | Ojjaara, Blenrep, Jemperli |
| Rigel Pharmaceuticals, INC. | $539.50 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $468.19 | 2021-2025 | Fruzaqla, Hyqvia, Ninlaro |
| Amgen INC. | $408.85 | 2021-2025 | Evenity, Nplate, Xgeva |
| Regeneron Healthcare Solutions, INC. | $399.88 | 2021-2025 | Libtayo |
| Genentech USA, INC. | $390.25 | 2021-2025 | Venclexta, Polivy, Tecentriq |
| Gilead Sciences, INC. | $369.78 | 2021-2025 | Trodelvy |
| Sobi, INC | $358.87 | 2022-2025 | |
| Incyte Corporation | $350.78 | 2021-2025 | Jakafi, Monjuvi |
| Bayer Healthcare Pharmaceuticals INC. | $344.33 | 2021-2025 | |
| Abbvie INC. | $328.60 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $323.16 | 2022-2025 | Ultomiris, Soliris |
| Aveo Pharmaceuticals, INC. | $322.74 | 2021-2025 | Fotivda |
| Boston Scientific Corporation | $295.94 | 2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Therasphere Y90 Glass Microspheres 10 Gbq |
| Springworks Therapeutics, INC. | $287.54 | 2024-2025 | Ogsiveo |
| Sanofi-Aventis U.S. LLC | $283.98 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $273.99 | 2021-2025 | |
| Taiho Oncology, INC. | $263.91 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $244.85 | 2021-2025 | Onivyde, Somatuline Depot |
| Karyopharm Therapeutics INC. | $242.03 | 2021-2025 | Xpovio |
| Servier Pharmaceuticals LLC | $231.07 | 2021-2025 | |
| Array Biopharma INC | $229.11 | 2021-2025 | Lorbrena, Xalkori, Braftovi |
| Blueprint Medicines Corporation | $219.64 | 2021-2024 | Ayvakit |
| Pharmaessentia USA Corporation | $208.89 | 2024-2025 | Besremi |
| Puma Biotechnology, INC. | $205.45 | 2022-2025 | Nerlynx |
| Deciphera Pharmaceuticals INC. | $147.82 | 2021-2025 | Qinlock, Tgct, Romvimza |
| Adc Therapeutics America, INC. | $142.46 | 2021-2024 | |
| Alnylam Pharmaceuticals INC. | $134.81 | 2021-2023 | Givlaari |
| Kite Pharma, INC. | $123.93 | 2021-2023 | Yescarta |
| Kyowa Kirin, INC. | $115.88 | 2021-2025 | Poteligeo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.61 | 2021-2023 | Gilotrif |
| Exelixis INC. | $113.68 | 2022-2024 | Cabometyx |
| Apellis Pharmaceuticals, INC. | $112.91 | 2023-2025 | Empaveli |
| Stemline Therapeutics INC. | $108.41 | 2023-2024 | Orserdu |
| Geron Corporation | $101.30 | 2025 | Rytelo |
| Intuitive Surgical, INC. | $99.07 | 2022 | |
| Genmab U.S., INC. | $93.68 | 2023-2025 | Epkinly |
| Emd Serono, INC. | $93.02 | 2021-2024 | Bavencio |
| Immunocore Limited | $90.52 | 2023-2024 | Kimmtrak |
| Tolmar, INC. | $77.26 | 2023-2025 | Rubraca, Eligard |
| Sumitomo Pharma America, INC. | $74.12 | 2023-2024 | Orgovyx, Gemtesa |
| Beigene USA, INC. | $71.16 | 2023-2024 | Brukinsa |
| Pharmacosmos Therapeutics INC. | $70.85 | 2021-2025 | Monoferric |
| Agios Pharmaceuticals, INC. | $68.71 | 2025 | Pyrukynd |
| Pharmaand Gmbh | $56.04 | 2025 | Rubraca |
| Tersera Therapeutics LLC | $55.02 | 2022-2025 | Xermelo |
| Spectrum Pharmaceuticals INC. | $52.48 | 2025 | Rolvedon |
| Myovant Sciences INC. | $52.02 | 2021-2022 | |
| Mirati Therapeutics, INC. | $51.92 | 2023-2024 | Krazati |
| Legend Biotech USA INC. | $51.27 | 2025 | Carvykti |
| Janssen Pharmaceuticals, INC | $51.08 | 2021-2024 | Xarelto, Rybrevant |
| Dova Pharmaceuticals | $49.25 | 2021 | |
| Beone Medicines USA, INC. | $48.60 | 2025 | Brukinsa, Tevimbra |
| Pharmacyclics LLC, An Abbvie Company | $48.59 | 2021-2023 | Imbruvica |
| Azurity Pharmaceuticals, INC. | $47.05 | 2024-2025 | Vivimusta, Danziten |
| Mylan Institutional INC. | $42.94 | 2021-2022 | |
| Coherus Oncology, INC. | $40.97 | 2021-2022 | |
| Morphosys, US INC. | $40.46 | 2021-2023 | Monjuvi |
| Octapharma USA, INC. | $40.00 | 2023-2024 | Panzyga, Octagam Immune Globulin (Human) |
| Epizyme, INC. | $38.71 | 2022 | |
| Invivyd INC | $31.07 | 2025 | Pemgarda |
| Organon LLC | $26.56 | 2023 | Ontruzant |
| Tg Therapeutics, INC. | $25.29 | 2021 | |
| Allergan, INC. | $24.50 | 2022 | |
| Acceleron Pharma, INC. | $22.66 | 2021 | |
| Immunogen, INC. | $21.74 | 2023 | Elahere |
| Sun Pharmaceutical Industries INC. | $17.66 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.59 | 2025 | Adstiladrin |
| Amag Pharmaceuticals, INC. | $17.55 | 2021 | |
| Pharming Healthcare, INC. | $16.96 | 2024 | Ruconest |
| Recordati_rare_diseases_inc. | $16.84 | 2025 | Enjaymo |
Drugs and devices associated with these payments
Keytruda $1,051Rybrevant $890Enhertu $800Lenvima $642Darzalex $594Reblozyl $500Lynparza $473Tecvayli $429Ojjaara $420Talvey $394Opdivo $365Verzenio $337Venclexta $322Erleada $312Sarclisa $308Jaypirca $303Opdualag $300Fabhalta $286Ogsiveo $263Nubeqa $248Tavalisse $247Rezlidhia $247Libtayo $246Akeega $242Welireg $240Zepzelca $234Fotivda $212Pomalyst $209Besremi $209Ultomiris $208Injectafer $203Xofigo $200Trodelvy $198Calquence $198Ibrance $194Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) $190Carvykti $189Tukysa $185Padcev $181Ayvakit $180Imfinzi $177Scemblix $176Lonsurf $167Inqovi $167Onivyde $157Xpovio $148Fruzaqla $146Xtandi $144Kisqali $141Vyloy $135Jakafi $134Retevmo $130Jevtana $127Tibsovo $124Orgovyx $124Hyqvia $123Doptelet $121Epkinly $120Qinlock $114Orserdu $108Therasphere Y90 Glass Microspheres 10 Gbq $106Rubraca $102Rytelo $101Brukinsa $101Lorbrena $99.88Xalkori $99.88Pluvicto $98.97Promacta $97.66Keytruda Qlex $94.60Polivy $93.91Kimmtrak $90.52Tagrisso $88.70Idhifa $85.25Elitek $84.99Vonjo $84.94Tecentriq $83.46Cabometyx $81.89Poteligeo $79.96Somatuline Depot $78.16Ninlaro $77.39Eligard $77.26Braftovi $75.34Mektovi $75.34Monjuvi $74.63Besponsa $73.74Bosulif $73.74Lunsumio $72.42Gazyva $72.42Vitrakvi $71.01Stivarga $71.01Lutathera $69.30Pyrukynd $68.71Adcetris $63.82Enjaymo $62.85Alunbrig $62.00Evenity $61.12Balversa $59.68Empaveli $59.39Xospata $59.22Blenrep $55.40
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.